Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women

Launched by CAIRO UNIVERSITY · May 9, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring a treatment called transcutaneous electrical acupoint stimulation to see if it can help reduce painful menstrual cramps (dysmenorrhea) in women who have autoimmune diseases, specifically rheumatoid arthritis or systemic lupus erythematosus. The study aims to find out if this method can ease pain and prevent worsening of symptoms during menstruation for women in this group.

To participate in the trial, women must be between 25 and 40 years old, have a body mass index (BMI) between 18.5 and 30, and experience severe pain during their menstrual periods. It's important that participants have regular menstrual cycles and are diagnosed with one of the specified autoimmune diseases. The trial is currently not recruiting participants yet, but when it does, those involved can expect to receive this treatment and be monitored for any changes in their pain levels and overall well-being during their menstrual cycles.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • All women will be diagnosed with Rheumatoid arthritis(RA) or Systemic lupus erythematosus (SLE).
• • All women will suffer from severe pain during menstruation
• • Age will range from 25-40 years old.
• • Body mass index: 18.5- 30 Kg/m²
• • All women participated in the study will have regular menstrual cycle
• Exclusion Criteria:
• • Secondary dysmenorrhea
• • Any other autoimmune diseases not mention in research
• • Cardiac or respiratory diseases
• • Vaginal infection
• • Anemia diseases